Skip to main content
  • Jul 03, 2024

    Strategies to Reduce Vision Loss in nAMD Using Long-Acting Anti-VEGF Therapies

    Retina/Vitreous
    Course CME
    0.5 General AMA PRA Category 1 Credits™

    In a series of 3 patient simulation cases, learn how the more durable anti-VEGF agents, aflibercept 8 mg and faricimab, can be used to treat neovascular AMD (nAMD). Compare your management decisions with current evidence, including a score with rationale.